AbCellera Biologics Inc. (ABCL) free cash flow

Free cash flow · fiscal 2025
-$174.07M

AbCellera Biologics Inc. (ABCL) generated free cash flow of -$174.07M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$186.95M. Figures as of 18 Nov 2026, 10:50 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$174.07M
Highest on record
$204.70Mfiscal 2022
Lowest on record
-$186.95Mfiscal 2024
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

AbCellera Biologics Inc. free cash flow, in more detail

Across the 7 fiscal years on record (2019–2025), the highest was $204.70M in fiscal 2022 and the lowest -$186.95M in fiscal 2024.

History · 7 fiscal years

Free cash flow by fiscal year

AbCellera Biologics Inc. free cash flow, year by year

AbCellera Biologics Inc. (ABCL) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$174.07M—
2024-$186.95M—
2023-$120.82M 159.0% down
2022$204.70M 10.0% up
2021$186.13M 1,329.9% up
2020$13.02M—
2019-$1.30M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on ABCL

AbCellera Biologics Inc., figure by figure

AbCellera Biologics Inc. (ABCL) overview: price, valuation and scorecard

AbCellera Biologics Inc. free cash flow: questions and answers

What is AbCellera Biologics Inc.'s free cash flow?

AbCellera Biologics Inc. (ABCL) generated free cash flow of -$174.07M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$186.95M.

What are the highest and lowest free cash flow figures on record for AbCellera Biologics Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was $204.70M in fiscal 2022 and the lowest -$186.95M in fiscal 2024.

How is AbCellera Biologics Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For AbCellera Biologics Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “AbCellera Biologics Inc. (ABCL) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/ABCL/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.